ReviewFrontiers in cardiovascular medicine2023

SGLT2 inhibitor improves the prognosis of patients with coronary heart disease and prevents in-stent restenosis.

Qing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.